Medifast, Inc. (NYSE:MED) Q1 2026 Earnings Call Transcript
Medifast, Inc. (NYSE:MED) Q1 2026 Earnings Call Transcript May 4, 2026Medifast, Inc. beats earnings expectations. Reported EPS is $-0.19, expectations were $-0.55.
Medifast Inc (MED)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 778,610 | $8,261,052 | +1% | 0.01% |
| 2. | Steamboat Capital Partners Parsa Kiai | 706,699 | $7,498,076 | -1% | 1.6% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 241,649 | $2,563,897 | 0% | |
| 4. | AQR Capital Management Cliff Asness | 236,434 | $2,508,564 | +63% | 0% |
| 5. | 233,400 | $2,476,374 | -68% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.26 | 1,175 | $14,409.26 | 20,270 | 2026-08-26 | Filing | |
| $12.26 | 41,975 | $514,747.82 | 707,492 | 2026-08-26 | Filing | |
| $12.00 | 118 | $1,415.95 | 19,095 | 2026-08-24 | Filing | |
| $12.00 | 4,211 | $50,530.32 | 665,517 | 2026-08-24 | Filing | |
| $11.60 | 1,175 | $13,634.35 | 18,977 | 2026-08-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $39.46 | 2,753 | $108,633.38 | 7,785 | 2024-03-08 | Filing | |
| $39.41 | 1,300 | $51,233.00 | 10,538 | 2024-03-08 | Filing | |
| $73.87 | 5,613 | $414,632.31 | 2,152 | 2023-10-06 | Filing | |
| $90.47 | 13,330 | $1,205,965.10 | 1 | 2023-08-15 | Filing | |
| $89.79 | 9,832 | $882,815.28 | 13,331 | 2023-08-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 542,700 | $5,758,047 | 0% | |
| 2. | 446,614 | $4,738,575 | 0% | |
| 3. | 396,996 | $4,212,128 | 0% | |
| 4. | 369,503 | $3,920,427 | 0% | |
| 5. | 363,394 | $3,855,669 | 0% |
News See All
Medifast, Inc. (NYSE:MED) Q4 2025 Earnings Call Transcript
Medifast, Inc. (NYSE:MED) Q4 2025 Earnings Call Transcript February 17, 2026Medifast, Inc. beats earnings expectations. Reported EPS is $-0.55, expectations were $-0.76.
Medifast, Inc. (NYSE:MED) Q3 2025 Earnings Call Transcript
Medifast, Inc. (NYSE:MED) Q3 2025 Earnings Call Transcript November 3, 2025Medifast, Inc. misses on earnings expectations. Reported EPS is $-0.21 EPS, expectations were $-0.01.
Medifast, Inc. (NYSE:MED) Q2 2025 Earnings Call Transcript
Medifast, Inc. (NYSE:MED) Q2 2025 Earnings Call Transcript August 4, 2025Medifast, Inc. beats earnings expectations. Reported EPS is $0.04, expectations were $-0.3.
Medifast, Inc. (NYSE:MED) Q1 2025 Earnings Call Transcript
Medifast, Inc. (NYSE:MED) Q1 2025 Earnings Call Transcript April 28, 2025Medifast, Inc. misses on earnings expectations. Reported EPS is $-0.11 EPS, expectations were $-0.07. Operator: Greetings.
Medifast, Inc. (NYSE:MED) Q4 2024 Earnings Call Transcript
Medifast, Inc. (NYSE:MED) Q4 2024 Earnings Call Transcript February 18, 2025Medifast, Inc. beats earnings expectations. Reported EPS is $0.1, expectations were $-0.16.
Medifast, Inc. (NYSE:MED) Q3 2024 Earnings Call Transcript
Medifast, Inc. (NYSE:MED) Q3 2024 Earnings Call Transcript November 4, 2024Medifast, Inc. beats earnings expectations. Reported EPS is $0.1029, expectations were $-0.28.
Medifast (MED): A Bull Case Theory
We came across a bullish thesis on Medifast (MED) on Value Degen’s Substack by Unemployed Value Degen. In this article we will summarize the bulls’ thesis on MED. Medifast, Inc.
Medifast, Inc. (NYSE:MED) Q2 2024 Earnings Call Transcript
Medifast, Inc. (NYSE:MED) Q2 2024 Earnings Call Transcript August 5, 2024Medifast, Inc. beats earnings expectations. Reported EPS is $0.92, expectations were $0.36.
Medifast, Inc. (NYSE:MED) Q1 2024 Earnings Call Transcript
Medifast, Inc. (NYSE:MED) Q1 2024 Earnings Call Transcript April 29, 2024 Medifast, Inc. misses on earnings expectations. Reported EPS is $0.66 EPS, expectations were $0.78.